News stories about NanoString Technologies (NASDAQ:NSTG) have trended somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. NanoString Technologies earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave media coverage about the biotechnology company an impact score of 46.2904266493734 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the media headlines that may have effected Accern’s scoring:
- Robert W. Baird Boosts NanoString Technologies (NSTG) Price Target to $15.00 (americanbankingnews.com)
- NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery (finance.yahoo.com)
- Iovance Biotherapeutics (IOVA) and NanoString Technologies (NSTG) Critical Analysis (americanbankingnews.com)
- Head to Head Survey: NanoString Technologies (NSTG) and Its Competitors (americanbankingnews.com)
A number of analysts have recently weighed in on the stock. Robert W. Baird increased their target price on shares of NanoString Technologies from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Monday. Zacks Investment Research lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Wednesday. ValuEngine upgraded shares of NanoString Technologies from a “sell” rating to a “hold” rating in a report on Friday, May 18th. BidaskClub upgraded shares of NanoString Technologies from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $12.00 target price (down from $13.00) on shares of NanoString Technologies in a report on Thursday, March 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $14.50.
NanoString Technologies opened at $14.29 on Thursday, Marketbeat Ratings reports. The company has a quick ratio of 2.67, a current ratio of 3.29 and a debt-to-equity ratio of 1.97. The stock has a market cap of $360.77 million, a PE ratio of -7.77 and a beta of 0.81. NanoString Technologies has a 1-year low of $5.87 and a 1-year high of $16.98.
NanoString Technologies (NASDAQ:NSTG) last posted its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.75) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.76) by $0.01. The company had revenue of $23.09 million during the quarter, compared to analyst estimates of $21.48 million. NanoString Technologies had a negative net margin of 36.62% and a negative return on equity of 108.29%. sell-side analysts predict that NanoString Technologies will post -2.77 earnings per share for the current year.
In related news, Director William Young acquired 30,000 shares of the stock in a transaction on Tuesday, March 13th. The stock was acquired at an average cost of $6.91 per share, for a total transaction of $207,300.00. Following the completion of the acquisition, the director now directly owns 30,000 shares of the company’s stock, valued at approximately $207,300. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 20.90% of the company’s stock.
About NanoString Technologies
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.